IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
The University of Queensland · QIMR Berghofer Medical Research Institute · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
851
total citations
- FWCI
- 33.19
- Percentile
- 100%
- References
- 199
Citations per year
Authors
7- MWMichele W.L. TengCorresponding
The University of Queensland, QIMR Berghofer Medical Research Institute
- EPEdward P. Bowman
Merck & Co., Inc., Rahway, NJ, USA (United States)
- JMJoshua McElwee
Merck & Co., Inc., Rahway, NJ, USA (United States)
- MJMark J. Smyth
The University of Queensland, QIMR Berghofer Medical Research Institute
- JCJean‐Laurent Casanova
Howard Hughes Medical Institute, Inserm, Université Paris Cité, Institut des Maladies Génétiques Imagine, Rockefeller University
Topics & keywords
Topics
Keywords
- Interleukin 23
- Ustekinumab
- Medicine
- Immune system
- Immunology
- Psoriasis
- Cytokine
- Proinflammatory cytokine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.